Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Accounts Payables (2020 - 2025)

Historic Accounts Payables for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to $1.2 million.

  • IceCure Medical's Accounts Payables fell 784.63% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 784.63%. This contributed to the annual value of $1.2 million for FY2024, which is 14541.83% up from last year.
  • IceCure Medical's Accounts Payables amounted to $1.2 million in Q3 2025, which was down 784.63% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, IceCure Medical's Accounts Payables ranged from a high of $714.0 million in Q4 2022 and a low of $502000.0 during Q4 2023
  • Over the past 5 years, IceCure Medical's median Accounts Payables value was $860000.0 (recorded in 2021), while the average stood at $40.5 million.
  • In the last 5 years, IceCure Medical's Accounts Payables skyrocketed by 8094426.79% in 2022 and then tumbled by 9992.97% in 2023.
  • Quarter analysis of 5 years shows IceCure Medical's Accounts Payables stood at $881000.0 in 2021, then surged by 80944.27% to $714.0 million in 2022, then plummeted by 99.93% to $502000.0 in 2023, then skyrocketed by 145.42% to $1.2 million in 2024, then decreased by 6.57% to $1.2 million in 2025.
  • Its Accounts Payables was $1.2 million in Q3 2025, compared to $1.2 million in Q2 2025 and $953000.0 in Q1 2025.